| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT06975787 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus… |
date change Primary completion pushed: 2028-07-23 -> 2029-09-09 |
| 2026-06-09 | NCT06975787 Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus… |
date change Completion pushed: 2028-07-23 -> 2029-09-09 |
| 2026-06-03 | NCT05092347 A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-03 | NCT05092347 A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic… |
Enrollment reduced: 56 -> 43 participants |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT05092347 | A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic… | Chronic Kidney Disease (CKD) | Active, Not Recruiting |
| Phase 1 | |||
| NCT06975787 | Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus… | Lupus Nephritis (LN) | Recruiting |
| Not specified | |||
| NCT05106387 | An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who… | Chronic Kidney Disease (CKD) | Recruiting |